Turtle Creek Wealth Advisors LLC Has $3.12 Million Position in Zoetis Inc. (NYSE:ZTS)

Turtle Creek Wealth Advisors LLC reduced its stake in shares of Zoetis Inc. (NYSE:ZTS) by 37.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,131 shares of the company’s stock after selling 11,390 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Zoetis were worth $3,117,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Hunter Associates Investment Management LLC increased its stake in shares of Zoetis by 7.8% in the fourth quarter. Hunter Associates Investment Management LLC now owns 2,009 shares of the company’s stock valued at $327,000 after buying an additional 146 shares in the last quarter. Cibc World Market Inc. increased its stake in shares of Zoetis by 44.2% in the fourth quarter. Cibc World Market Inc. now owns 162,446 shares of the company’s stock valued at $26,467,000 after buying an additional 49,774 shares in the last quarter. Sivik Global Healthcare LLC acquired a new stake in shares of Zoetis in the fourth quarter valued at $2,444,000. Crews Bank & Trust acquired a new stake in shares of Zoetis in the fourth quarter valued at $341,000. Finally, OLD Second National Bank of Aurora increased its stake in shares of Zoetis by 0.6% in the fourth quarter. OLD Second National Bank of Aurora now owns 11,756 shares of the company’s stock valued at $1,915,000 after buying an additional 72 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ZTS has been the subject of a number of research reports. Stifel Nicolaus lowered their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Leerink Partners started coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target on the stock. JPMorgan Chase & Co. raised their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Morgan Stanley decreased their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a report on Wednesday. Finally, UBS Group started coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $215.00.

Zoetis Price Performance

Shares of ZTS opened at $172.61 on Friday. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The stock has a market cap of $77.88 billion, a P/E ratio of 32.45, a price-to-earnings-growth ratio of 2.70 and a beta of 0.89. The stock’s 50-day moving average price is $169.74 and its two-hundred day moving average price is $179.54.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter in the previous year, the business posted $1.36 EPS. Zoetis’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, equities analysts predict that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Zoetis’s payout ratio is 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.